Target intelligence / Profile preview

DNA-directed RNA polymerase subunit beta-prime (bacterial RpoC) (RpoC)

Target
RpoC
Molecular classification
Enzyme: DNA-dependent RNA polymerase complex subunit, Transcription machinery: multi-subunit RNA polymerase core enzyme component, Other: DNA-binding protein; part of DNA-directed RNA polymerase complex
01

Overview

DNA-directed RNA polymerase subunit beta-prime (β′) is the largest subunit of the bacterial multi-subunit RNA polymerase core enzyme, encoded by rpoC; together with the β subunit it forms the catalytic center that synthesizes RNA from a DNA template during transcription. The bacterial RNAP core comprises α2ββ′ω and associates with a sigma factor (σ) to form the holoenzyme for promoter-specific initiation. The β′ subunit contributes to the active center and mediates extensive, largely non-sequence-specific contacts with DNA and nascent RNA; in cyanobacteria and chloroplasts, β′ is split into β′ and β″ (often rpoC1 and rpoC2). As a component of the essential bacterial RNAP, β′ is part of the molecular complex targeted by antibacterial agents such as rifamycins that inhibit transcription, although rifamycins classically bind within the β subunit channel.

Other names
RNA polymerase subunit beta-primeRNAP subunit beta′Transcriptase subunit beta′rpoC gene product (Escherichia coli K-12)EC 2.7.7.6 subunit β′Beta-prime subunit of DNA-dependent RNA polymeraseIn cyanobacteria/chloroplasts: split β′ into β′ and β″ (sometimes termed rpoC1/rpoC2)
02

Mechanism of action

Inhibition of bacterial DNA-dependent RNA polymerase to block transcription initiation/elongation, leading to suppression of RNA synthesis and bacterial cell death or stasis (classically by rifamycins binding within the RNAP β subunit channel; activity disables the RNAP complex containing β′)

03

Biological functions

Catalytic center contribution to RNA synthesis during DNA-templated transcriptionDNA binding and non-sequence-specific interactions with DNA and nascent RNAParticipation in transcription initiation and elongation as part of RNAP core/holoenzymeLocalization to cytoplasm/cytosol and RNAP complex
04

Disease associations

Infection: Essential bacterial enzyme; component of the RNAP targeted by antibacterial drugs and implicated in antimicrobial resistance selection (notably via mutations in rpoB; β′ is in the same essential enzyme complex)
05

Safety considerations

Therapeutic challenges relate to antibacterial RNAP inhibitors: Rapid resistance emergence via RNAP subunit mutations (commonly rpoB; complex integrity includes β′)Off-target human toxicity is limited because human nuclear RNAPs differ structurally; however, microbiome disruption and drug–drug interactions (notably with rifamycins) are clinical concerns at the drug level rather than the subunit per seTarget accessibility in Gram-negative bacteria due to permeability/efflux can limit efficacy; relates to drug delivery to RNAP complex
06

Interacting drugs

Rifamycins (class; primarily bind β/RpoB but functionally target bacterial RNAP that includes β′): rifampin, rifabutin, rifapentine

1 more in the full profile.

07

Biomarkers

Genomic markers in the RNAP locus used in antimicrobial targeting/resistance workflows: rpoB mutations (rifamycin resistance determinant; inform RNAP-targeting therapy decisions while β′ remains in the same complex)rpoC mutations can arise under antibiotic pressure and may modulate RNAP function; gene symbol rpoC encodes β′ in E. coliOrganism identification of bacterial pathogens possessing canonical multi-subunit RNAP (β and β′) to predict susceptibility to RNAP inhibitors

Beyond the preview

Go deeper on DNA-directed RNA polymerase subunit beta-prime (bacterial RpoC) (RpoC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA-directed RNA polymerase subunit beta-prime (bacterial RpoC) (RpoC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call